You are here

NEW CTMSS Education Slide Deck: Transcranial Magnetic Stimulation (TMS) - An Introduction

×

Warning message

This Grand Rounds Webinar is restricted to registered participants or on-demand registrants. Click the following link to register: Register Here

NEW CTMSS Education Slide Deck: Transcranial Magnetic Stimulation (TMS) - An Introduction

You’re invited to join the Clinical TMS Society for this installment of our Grand Rounds Webinar Series:
NEW CTMSS Education Slide Deck: Transcranial Magnetic Stimulation (TMS) - An Introduction 

Learning objectives: 

1.     Understand the history of and science behind Transcranial Magnetic Stimulation (TMS);

2.     Understand indications and contraindications of TMS;

3.     Understand the pivotal literature on TMS in the treatment of depression and OCD;

4.     Understand the risks and side effects of TMS.

 

*At the conclusion of this Grand Round webinar, the Community Education Slide Deck will be made available to Clinical TMS Society members for educational purposes by completing the Member User Agreement.  
 

Date of Release: January 7, 2020

Date of Expiration: January 6, 2022

Time: 8:00 pm EST, 5:00 pm PST

Format: On-Demand

Cost: Members: $25 | Non-members $50 | Student Members FREE

Speaker: Mark George, MD

Dr. George is a world expert in brain stimulation, and depression, and is the editor-in-chief of a new journal he co-launched with Elsevier in 2008 called, Brain Stimulation: Basic, Translation and Clinical Research in Neuromodulation. He has been continuously funded by NIH and other funding agencies since his fellowships. He performed early pioneering work with TMS for depression, and combining TMS with brain imaging. After his research fellowship at the NIMH intramural program where he first delivered TMS for depression, he received both a NARSAD Young Investigator and Independent Investigator Award to further pursue TMS research in depression. He has received numerous international awards including the NARSAD Klerman Award (2000), NARSAD Falcone Award (2008) and the Lifetime Achievement Award (2007) given by the World Federation of Societies of Biological Psychiatry (WFSBP). In 2009 US News and World Report named him one of 14 ‘medical pioneers who are not holding back’. He has published over 500 scientific articles or book chapters, and has written or edited 6 books. He lives on the beach, kite surfs, raises bees and chickens, and recently gathered TMS motor thresholds in zero-gravity. 

Vertical Tabs

Vertical Tabs

 


Acknowledgement of Financial and/or In-Kind Commercial Support

No financial or in-kind commercial support was received for this educational activity.

Satisfactory Completion 

Learners must complete an evaluation form to receive a certificate of completion. You must participate in the entire webinar as partial credit is not available. If you are seeking continuing education credit for a specialty not listed below, it is your responsibility to contact your licensing/certification board to determine course eligibility for your licensing/certification requirement.   

Physicians             

In support of improving patient care, this activity has been planned and implemented by Amedco LLC and the Clinical TMS Society. Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. Credit Designation Statement – Amedco LLC designates this enduring material activity for a maximum of 1 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

Disclosure of Conflict of Interest

The following table of disclosure information is provided to learners and contains the relevant financial relationships that each individual in a position to control the content disclosed to Amedco.  All of these relationships were treated as a conflict of interest, and have been resolved.  (C7 SCS 6.1-­‐6.2, 6.5)

All individuals in a position to control the content of CE are listed below.

Diversified mutual fund including stocks in pharmaceutical companies. :Stock Shareholder

 

First Name

Last Name

Commercial Interest:Relationship

Mo

Abdelghani

Takeda Pharmaceuticals:Consultant,Takeda Pharmaceuticals:Scientific/Medical Advisory Board Member,DM Practice Management:Other,Takeda Pharmaceuticals:Speakers Bureau,London TMS Centre:Owner and director,Dyad Medical Ltd:Other

Richard

Bermudes

American Psychiatric Association Publishing:Other

Mark 

George

Brainsway:Research Grant Overall Principal Investigator, Magstim:Loaned equipment,MECTA:Research Grant Site Principal Investigator,Microtransponder:DSMB member,Neosync:DSMB member

Bobbie

Fleming

NA

Todd

Hutton

Neuronetics:Speakers Bureau,Southern California TMS Center:Stock Shareholder

Sheryl

Morgan

NA

Bob

Sammons

NA

Questions? Email Certificate@AmedcoEmail.com